Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FBYLQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,421
Award facts
- Contract value 100% obligated
- $1,420.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,420.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 68 milligram Nexplanon implants. The contract, designated as delivery order 4570232114, employs firm fixed-price pricing with an ultimate completion date of December 29, 2025, and was issued without a set-aside designation. This delivery order is executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with a $499.999 billion ceiling established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, and extends through December 31, 2036.
The PPV-G GEN V program represents a comprehensive $30.3 billion acquisition strategy designed to support the Department of Defense's recurring pharmaceutical and medical supply requirements across military healthcare facilities worldwide. DMS Pharmaceutical Group functions as a regional prime vendor contractor within this broader framework, authorized to supply branded and generic prescription medications, biologics, vaccines, and medical consumables under firm fixed-price delivery orders. The company's selection as a prime vendor reflects its demonstrated capability to fulfill specialized pharmaceutical requirements, as evidenced by substantial recent contracting activity with the Defense Logistics Agency's Medical Supply Chain division throughout October and November 2025, positioning it as a critical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBYLQ?
SPE2DR26FBYLQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FBYLQ worth?
The government has obligated $1,421 on SPE2DR26FBYLQ.
Is contract SPE2DR26FBYLQ an order under another contract?
Yes. SPE2DR26FBYLQ is a delivery order under SPE2DR25D9103, an indefinite delivery contract.
Was contract SPE2DR26FBYLQ competed?
The extent of competition for SPE2DR26FBYLQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award